相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HHLA2 immune-regulatory roles in cancer
Keywan Mortezaee
BIOMEDICINE & PHARMACOTHERAPY (2023)
The impact of oncolytic adenoviral therapy on the therapeutic efficacy of PD-1/PD-L1 blockade
Sajad Najafi et al.
BIOMEDICINE & PHARMACOTHERAPY (2023)
B7x in cancer immunity and immunotherapy
Keywan Mortezaee
INTERNATIONAL IMMUNOPHARMACOLOGY (2023)
Bypassing anti-PD-(L)1 therapy: Mechanisms and management strategies
Keywan Mortezaee et al.
BIOMEDICINE & PHARMACOTHERAPY (2023)
(Im)maturity in Tumor Ecosystem
Keywan Mortezaee et al.
FRONTIERS IN ONCOLOGY (2022)
Circular RNAs as emerging players in cervical cancer tumorigenesis; A review to roles and biomarker potentials
Sajad Najafi
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)
Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments
Saife N. Lone et al.
MOLECULAR CANCER (2022)
Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy
Keywan Mortezaee et al.
CELLULAR ONCOLOGY (2022)
The impact of microbiota on PD-1/PD-L1 inhibitor therapy outcomes: A focus on solid tumors
Sajad Najafi et al.
LIFE SCIENCES (2022)
Long non-coding RNAs (lncRNAs); roles in tumorigenesis and potentials as biomarkers in cancer diagnosis
Sajad Najafi et al.
EXPERIMENTAL CELL RESEARCH (2022)
Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy
Elnaz Rouzbahani et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Cancer vaccines: the next immunotherapy frontier
Matthew J. Lin et al.
NATURE CANCER (2022)
Molecular functions and therapeutic applications of exosomal noncoding RNAs in cancer
Qin-Wen Liu et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2022)
Redox tolerance and metabolic reprogramming in solid tumors
Keywan Mortezaee
CELL BIOLOGY INTERNATIONAL (2021)
Enriched cancer stem cells, dense stroma, and cold immunity: Interrelated events in pancreatic cancer
Keywan Mortezaee
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2021)
Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics
Julianne D. Twomey et al.
AAPS JOURNAL (2021)
Organ tropism in solid tumor metastasis: an updated review
Keywan Mortezaee
FUTURE ONCOLOGY (2021)
The Advantages and Challenges of Anticancer Dendritic Cell Vaccines and NK Cells in Adoptive Cell Immunotherapy
Elena V. Abakushina et al.
VACCINES (2021)
The ever-increasing importance of cancer as a leading cause of premature death worldwide
Freddie Bray et al.
CANCER (2021)
Normalization in tumor ecosystem: Opportunities and challenges
Keywan Mortezaee
CELL BIOLOGY INTERNATIONAL (2021)
The current knowledge concerning solid cancer and therapy
Masoud Najafi et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2021)
Myeloid-derived suppressor cells in cancer immunotherapy-clinical perspectives
Keywan Mortezaee
LIFE SCIENCES (2021)
New approaches and procedures for cancer treatment: Current perspectives
Dejene Tolossa Debela et al.
SAGE OPEN MEDICINE (2021)
Improvement of DC-based vaccines using adjuvant TLR4-binding 60S acidic ribosomal protein P2 and immune checkpoint inhibitors
Gun-Young Jang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Resveratrol as an Adjuvant for Normal Tissues Protection and Tumor Sensitization
Keywan Mortezaee et al.
CURRENT CANCER DRUG TARGETS (2020)
Gastric cancer prevention strategies: A global perspective
Leonardo Henry Eusebi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
A review on methods for diagnosis of breast cancer cells and tissues
Ziyu He et al.
CELL PROLIFERATION (2020)
Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors
Vid Leko et al.
CANCER CELL (2020)
Why and How Vaccines Work
Akiko Iwasaki et al.
CELL (2020)
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert
NATURE COMMUNICATIONS (2020)
Dendritic cell biology and its role in tumor immunotherapy
Yingying Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
The role of curcumin/curcuminoids during gastric cancer chemotherapy: A systematic review of non-clinical study
Masoud Najafi et al.
LIFE SCIENCES (2020)
TGF-β Mediated Immune Evasion in Cancer-Spotlight on Cancer-Associated Fibroblasts
Parisa Ghahremanifard et al.
CANCERS (2020)
Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model
Chiao-Fang Teng et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Hypoxia-induced TGF-β-RBFOX2-ESRP1 axis regulates human MENA alternative splicing and promotes EMT in breast cancer
Neha Ahuja et al.
NAR CANCER (2020)
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination
Tanja Lovgren et al.
ONCOIMMUNOLOGY (2020)
A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine
Hyun Jin Park et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Trial watch: dendritic cell vaccination for cancer immunotherapy
Jenny Sprooten et al.
ONCOIMMUNOLOGY (2019)
New Hope for Therapeutic Cancer Vaccines in the Era of Immune Checkpoint Modulation
Michael A. Curran et al.
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer
Alberto A. Chiappori et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Stromal reprogramming: A target for tumor therapy
Masoud Najafi et al.
LIFE SCIENCES (2019)
Accumulation of genetic and epigenetic alterations in normal cells and cancer risk
Hideyuki Takeshima et al.
NPJ PRECISION ONCOLOGY (2019)
Current Cancer Epidemiology
Camilla Mattiuzzi et al.
JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH (2019)
Pro-inflammatory allogeneic DCs promote activation of bystander immune cells and thereby license antigen-specific T-cell responses
Grammatiki Fotaki et al.
ONCOIMMUNOLOGY (2018)
Dendritic cell vaccine induces antigen-specific CD8+ T cells that are metabolically distinct from those of peptide vaccine and is well-combined with PD-1 checkpoint blockade
Koji Nagaoka et al.
ONCOIMMUNOLOGY (2018)
Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models
Grammatiki Fotaki et al.
ONCOIMMUNOLOGY (2018)
Mechanisms of resistance to immune checkpoint inhibitors
Russell W. Jenkins et al.
BRITISH JOURNAL OF CANCER (2018)
Clinical Variables Associated With Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Sipuleucel-T Immunotherapy
Xiao X. Wei et al.
CLINICAL GENITOURINARY CANCER (2018)
Cancer vaccines: translation from mice to human clinical trials
Hoyoung Maeng et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy
Yared Hailemichael et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer
Janos L. Tanyi et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Molecular signatures associated with tumor-specific immune response in melanoma patients treated with dendritic cell-based immunotherapy
Tamara García-Salum et al.
Oncotarget (2018)
Combination immunotherapy: Taking Cancer vaccines to the next Level
Jeremy M. Grenier et al.
FRONTIERS IN IMMUNOLOGY (2018)
Immune-related adverse events from combination immunotherapy in cancer patients: A comprehensive meta-analysis of randomized controlled trials
Bo Zhang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Immune cell subset differentiation and tissue inflammation
Pu Fang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
The dawn of vaccines for cancer prevention
Olivera J. Finn
NATURE REVIEWS IMMUNOLOGY (2018)
Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment
Mansi Saxena et al.
TRENDS IN CANCER (2018)
HPV vaccines - A review of the first decade
Diane M. Harper et al.
GYNECOLOGIC ONCOLOGY (2017)
Dendritic cell-based immunotherapy: a basic review and recent advances
Joao Constantino et al.
IMMUNOLOGIC RESEARCH (2017)
A retrospective analysis comparing APCEDEN® dendritic cell immunotherapy with best supportive care in refractory cancer
Chaitanya Kumar et al.
IMMUNOTHERAPY (2017)
Vaccination with poly (IC: LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer
Shikhar Mehrotra et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma
Keitaro Fukuda et al.
MELANOMA RESEARCH (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Combination therapy of cancer with cancer vaccine and immune checkpoint inhibitors: A mathematical model
Xiulan Lai et al.
PLOS ONE (2017)
Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations
Margaret E. Gatti-Mays et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Human tumor-derived exosomes (TEX) regulate Treg functions via cell surface signaling rather than uptake mechanisms
Laurent Muller et al.
ONCOIMMUNOLOGY (2017)
CANCER SCREENING AND EARLY DETECTION IN THE 21ST CENTURY
Jennifer T. Loud et al.
SEMINARS IN ONCOLOGY NURSING (2017)
Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
Chunlei Ge et al.
BMC CANCER (2017)
Immune Responses and Long-Term Disease Recurrence Status After Telomerase-Based Dendritic Cell Immunotherapy in Patients With Acute Myeloid Leukemia
Hanna J. Khoury et al.
CANCER (2017)
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination
Kristen A. Batich et al.
CLINICAL CANCER RESEARCH (2017)
Targeting neoantigens to augment antitumour immunity
Mark Yarchoan et al.
NATURE REVIEWS CANCER (2017)
Dendritic cells in cancer: the role revisited
Filippo Veglia et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study
Per Kongsted et al.
CYTOTHERAPY (2017)
Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines
Oezlem Tuereci et al.
CLINICAL CANCER RESEARCH (2016)
In situ vaccination for the treatment of cancer
Linda Hammerich et al.
IMMUNOTHERAPY (2016)
The present status and future prospects of peptide-based cancer vaccines
Masatoshi Hirayama et al.
INTERNATIONAL IMMUNOLOGY (2016)
Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
Sofie Wilgenhof et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
TCR Sequencing Can Identify and Track Glioma-Infiltrating T Cells after DC Vaccination
Melody S. Hsu et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Global burden of cancers attributable to infections in 2012: a synthetic analysis
Martyn Plummer et al.
LANCET GLOBAL HEALTH (2016)
Treatment of prostate cancer: therapeutic potential of targeted immunotherapy with APC8015
Robert Bok
Therapeutics and Clinical Risk Management (2016)
Systemic treatment with anti-PD-1 antibody nivolumab in combination with vaccine therapy in advanced pancreatic cancer
Jan Nesselhut et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Vaccines for established cancer: overcoming the challenges posed by immune evasion
Sjoerd H. van der Burg et al.
NATURE REVIEWS CANCER (2016)
Historical review of the causes of cancer
Clarke Brian Blackadar
WORLD JOURNAL OF CLINICAL ONCOLOGY (2016)
Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors
Soumaya Karaki et al.
VACCINES (2016)
Dendritic-Tumor Fusion Cell-Based Cancer Vaccines
Shigeo Koido
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
PD-1 blockade enhances the vaccination-induced immune response in glioma
Joseph P. Antonios et al.
JCI INSIGHT (2016)
The role of myeloid cells in cancer therapies
Camilla Engblom et al.
NATURE REVIEWS CANCER (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
CANCER IMMUNOTHERAPY Dendritic-cell vaccines on the move
Rachel Lubong Sabado et al.
NATURE (2015)
mRNA-based dendritic cell vaccines
Daphne Benteyn et al.
EXPERT REVIEW OF VACCINES (2015)
Clinical use of dendritic cells for cancer therapy
Sebastien Anguille et al.
LANCET ONCOLOGY (2014)
Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
Madhav V. Dhodapkar et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
DCVax®-L-Developed by Northwest Biotherapeutics
Stavros Polyzoidis et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Trial watch: Dendritic cell-based anticancer therapy
Norma Bloy et al.
ONCOIMMUNOLOGY (2014)
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Pierre G. Coulie et al.
NATURE REVIEWS CANCER (2014)
Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer
Nadeem A. Sheikh et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Karolina Palucka et al.
IMMUNITY (2013)
Vaccine delivery carriers: Insights and future perspectives
J. F. Correia-Pinto et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Tumor Markers in Clinical Practice: A Review Focusing on Common Solid Cancers
Michael J. Duffy
MEDICAL PRINCIPLES AND PRACTICE (2013)
Dendritic Cells in the Cancer Microenvironment
Yang Ma et al.
JOURNAL OF CANCER (2013)
Cancer vaccines Looking to the future
Kavitha Yaddanapudi et al.
ONCOIMMUNOLOGY (2013)
Dendritic cell-based vaccines: barriers and opportunities
Jessica A. Cintolo et al.
FUTURE ONCOLOGY (2012)
Future directions in cancer prevention
Asad Umar et al.
NATURE REVIEWS CANCER (2012)
Combining immunotherapy and targeted therapies in cancer treatment
Matthew Vanneman et al.
NATURE REVIEWS CANCER (2012)
Immunotherapy for Prostate Cancer: Recent Advances, Lessons Learned, and Areas for Further Research
James L. Gulley et al.
CLINICAL CANCER RESEARCH (2011)
Phase I Study Utilizing a Novel Antigen-Presenting Cell-Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients
Michael A. Morse et al.
CLINICAL CANCER RESEARCH (2011)
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2011)
The dendritic cell-tumor cross-talk in cancer
Yuting Ma et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Complexity of dendritic cell subsets and their function in the host immune system
Rahul Kushwah et al.
IMMUNOLOGY (2011)
Immunological mechanisms of vaccination
Bali Pulendran et al.
NATURE IMMUNOLOGY (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Inflammation and Cancer: Causes and Consequences
M. M. Moore et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Current status of immunological therapies for prostate cancer
Emmanuel S. Antonarakis et al.
CURRENT OPINION IN UROLOGY (2010)
Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth
Albert Lin et al.
IMMUNOLOGY LETTERS (2010)
Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma
Antoni Ribas et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Whole tumor antigen vaccines
Cheryl Lai-Lai Chiang et al.
SEMINARS IN IMMUNOLOGY (2010)
Cancer Prevention With Natural Compounds
Norleena P. Collett et al.
SEMINARS IN ONCOLOGY (2010)
Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma
Antoni Ribas et al.
CLINICAL CANCER RESEARCH (2009)
Cancer prevention research - then and now
Ann M. Bode et al.
NATURE REVIEWS CANCER (2009)
Prevention of cancer through immunization:: Prospects and challenges for the 21st century
Ian H. Frazer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Role of tumor markers in patients with solid cancers: A critical review
Michael J. Duffy
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2007)
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer
Eric J. Small et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The global health burden of infection -associated cancers in the year 2002
Donald Maxwell Parkin
INTERNATIONAL JOURNAL OF CANCER (2006)
Dendritic cells as therapeutic vaccines against cancer
J Banchereau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
A listing of human tumor antigens recognized by T cells: March 2004 update
L Novellino et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity
SC Yang et al.
CLINICAL CANCER RESEARCH (2004)
Current developments of immunotherapy in the clinic
S Antonia et al.
CURRENT OPINION IN IMMUNOLOGY (2004)
Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis
NS Wilson et al.
BLOOD (2004)
Antitumor effects of vaccine consisting of dendritic cells pulsed with tumor RNA from gastric cancer
Bing-Ya Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
D Lavanchy
JOURNAL OF VIRAL HEPATITIS (2004)
DNA vaccines to attack cancer
FK Stevenson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Tumors as elusive targets of T-cell-based active immunotherapy
FM Marincola et al.
TRENDS IN IMMUNOLOGY (2003)
Rational approaches to human cancer immunotherapy
ID Davis et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Dendritic cell-based cancer immunotherapy: Potential for treatment of colorectal cancer?
WX Chen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)
分享论文
